Inflammation Medicine - From Bench to Bedside

In 2019, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” started in a new period funded through the German Excellence Strategy (DFG). Its goal is to establish precision medicine in inflammation medicine by translating interdisciplinary research findings on chronic inflammatory diseases to clinical use.

Precision medicine in inflammation medicine also defines the focus of our International Symposium “Inflammation Medicine – From Bench to Bedside” in 2020. In this symposium, we bring together a broad diversity of scientists in the field of inflammation research and precision medicine. In focused plenary sessions and parallel workshops, we want to discuss solutions in a series of scientific fields that have recently received attention through the progress made in inflammation medicine. The sessions will cover
several aspects of precision medicine, ranging from high resolution imaging to genetics, from the microbiome as a target to prediction medicine.

Two parallel clinical sessions will focus on existing and novel therapeutic options in individualized medicine and are sponsored by Sanofi and Abbvie.

Adressinfo:
Radisson Blu
Straße:
Marseiller Straße 2
Plz:
20355
Ort:
Hamburg
Land:
Deutschland
Veranstalter

Cluster of Excellence PMI - Precision Medicine in Chronic Inflammation

Kiel University
Christian-Albrechts-Platz 4
24118 Kiel
Phone: +49 (0) 431 880 4850
Fax: +49 (0) 431 880 4894

Management

Executive Group of the Cluster

Stefan Schreiber, Dept. of Internal Med. I, Kiel University
Stefan Niemann, Mycobacteriology Research Center Borstel
Gabriela Riemekasten, Dept. of Rheumatology, University of Lübeck

Registrier-Email
office@precisionmedicine.de
Zeitpunkt
17.02.2020 08:00 bis 18.02.2020 20:00
Autor
Frau Dr. habil. Susanne Holstein
Themen
Fortbildungsveranstaltung
Quelle
PMI
Webseite der Veranstaltung